These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16770555)

  • 1. Molecular basis of obesity and the risk for cardiovascular disease.
    Soufi M; Sattler AM; Herzum M; Maisch B; Schaefer JR
    Herz; 2006 May; 31(3):200-6. PubMed ID: 16770555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, inflammation, and cardiovascular risk.
    Mathieu P; Lemieux I; Després JP
    Clin Pharmacol Ther; 2010 Apr; 87(4):407-16. PubMed ID: 20200516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
    El-Atat FA; Stas SN; McFarlane SI; Sowers JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity: effects on cardiovascular disease and its diagnosis.
    Mathew B; Francis L; Kayalar A; Cone J
    J Am Board Fam Med; 2008; 21(6):562-8. PubMed ID: 18988724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic fat and cardiovascular disease: what is the link?
    Gastaldelli A; Basta G
    Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):481-90. PubMed ID: 20659791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition and cardiovascular disease.
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2499-506. PubMed ID: 17954523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update.
    Selwyn AP
    Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and cardiovascular disease: from pathophysiology to risk stratification.
    Marinou K; Tousoulis D; Antonopoulos AS; Stefanadi E; Stefanadis C
    Int J Cardiol; 2010 Jan; 138(1):3-8. PubMed ID: 19398137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
    Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women.
    Jarvis CM; Hayman LL; Braun LT; Schwertz DW; Ferrans CE; Piano MR
    J Cardiovasc Nurs; 2007; 22(6):429-35. PubMed ID: 18090180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
    Chen L; Peeters A; Magliano DJ; Shaw JE; Welborn TA; Wolfe R; Zimmet PZ; Tonkin AM
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):740-5. PubMed ID: 18043293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria and obesity: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):40-5. PubMed ID: 18803675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.
    Ramel A; Pumberger C; Martinéz AJ; Kiely M; Bandarra NM; Thorsdottir I
    Nutr Res; 2009 May; 29(5):305-12. PubMed ID: 19555811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do current body mass index criteria for obesity surgery reflect cardiovascular risk?
    Livingston EH; Chandalia M; Abate N
    Surg Obes Relat Dis; 2007; 3(6):577-85. PubMed ID: 17936086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.